Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study): protocol for a partially randomised patient preference trial.
Marleen BouhuysWillem S LexmondGerard DijkstraTriana LobatónEdouard LouisStephanie van BiervlietHenk GroenJordi GuardiolaPatrick Ferry van RheenenPublished in: BMJ open (2021)
EudraCT number: 2020-001811-26; ClinicalTrials.gov Identifier: NCT04646187. Protocol version 4, date 17 September 2021.
Keyphrases